# Bami Adenipekun

Bami Adenipekun is a health equity consultant and patient advocate. Through Inspired To Soar, Bami focuses on racial disparities in healthcare and on turning community experiences into changes in how health services work.

- Profile: https://b2binfluencer.marketing/creators/bami-adenipekun/
- LinkedIn: https://www.linkedin.com/in/bami-adenipekun-inspiredtosoar
- LinkedIn followers: 1,553
- Topics: healthcare
- Based on 11 dated posts, latest 2026-09-23

## Summary

Useful for health equity and patient advocacy work that turns community voices into service or policy change.

- Best for: UK health organisations or NHS partners improving community engagement on racial disparities in cancer care.
- Not for: National consumer brands seeking broad product awareness through lifestyle video and mass reach.
- Check first: Confirm sponsorship acceptance, audience analytics, scope, fees and usage terms before contacting.

### Takeaways

- Listening is only the beginning; organisations should report what they heard and what they will do.
- Cancer equity is a test of whether the health system serves the population.
- Inequity appears across cancer, diabetes, cardiovascular health and mental health, so work is not single-issue.

## Main ideas

- **Health equity is a test of whether a system is fit for purpose, not a diversity add-on**: Bami Adenipekun's case for cancer equity starts with scale. If a condition is going to affect roughly half the population born after 1960, differences in who gets diagnosed late, who gets treated and who survives are not a side issue for a diversity calendar. The reasoning runs from volume to system design: a health service that produces unequal outcomes at that scale is not coping with the population it serves, and rising incidence makes that weakness worse. The argument is aimed at people who control budgets and equality plans, and deliberately avoids blaming individuals or communities.
- **Listening is not engagement — the loop has to close**: This is the most concrete working method in the available material. In Bami Adenipekun's description, most healthcare community engagement stops at the listening stage: a survey goes out, a focus group happens, someone writes it up, and everyone moves to the next priority. For people from ethnic minority communities who have already had to fight to be believed by the health system, silence afterwards is not neutral — it confirms that speaking up changes nothing. The alternative is slower and less comfortable: go back to the people who spoke, tell them what was heard and what is being done about it, then repeat. Follow-through is part of the engagement, not an optional extra.
- **Inequity shows up across conditions, so the work is never single-issue**: Bami Adenipekun argues that the same pattern — systemic gaps meeting cultural attitudes — appears in diabetes, cardiovascular health and mental health, not only cancer. Recurring examples include later diagnosis, higher rates of complications, and reluctance to seek mental health support because of stigma within a community, layered on a service that does not feel built for that community. The reasoning is transferable: fix the thinking behind one condition and the lessons travel to others. The topic boundaries are wider than a single-disease campaign would assume.
- **Advocacy built on lived experience, with trauma recovery as practical guidance**: Bami Adenipekun treats personal history as the source of the work rather than background colour. Their account moves from caring responsibilities as a teenager, through study and a Masters in International Development and Human Rights, to a career in patient advocacy after a sister's cancer diagnosis and their own diagnosis showed the racial inequities in the health system. Their priority is practical: people who have been through trauma should not just be heard; they should be given something usable. That is why the writing is framed as a roadmap and paired with advice to build a supportive community rather than soldier on alone.
- **Bring the whole system into one room**: The convening approach follows from the loop-closing argument: if engagement only works when the people who can act are present, statutory services, voluntary and non-statutory organisations, and communities themselves need to be in the same conversation, not consulted separately. Bami Adenipekun presents this as unusual enough to be worth stating and ties it to a specific topic rather than health equity in the abstract.

## Work to read

- [A 15-year gap between two photographs, and how patient advocacy became the work](https://www.linkedin.com/posts/bami-adenipekun-inspiredtosoar_patientadvocacy-healthequity-traumarecovery-activity-7497156124798947329-VnBh)
- [The scale of cancer in the UK, and why cancer equity is framed as a system test](https://www.linkedin.com/posts/bami-adenipekun-inspiredtosoar_seenheardvalued-cancerawareness-healthequity-activity-7499028059707047936-qgg6)
- [Community engagement that goes beyond listening and reports back](https://www.linkedin.com/posts/bami-adenipekun-inspiredtosoar_seenheardvalued-healthequity-culturalsafety-activity-7490706954013683712-xnD3)
- [A video on why cancer care became the focus of the consultancy](https://www.linkedin.com/posts/bami-adenipekun-inspiredtosoar_seenheardvalued-turningvoicesintochange-healthequity-activity-7498287081367003136-LH-1)
- [Health inequity treated as a pattern across conditions, not a single issue](https://www.linkedin.com/posts/bami-adenipekun-inspiredtosoar_healthinequity-mentalhealthmatters-diabetesawareness-activity-7508433971970514944-hey5)

## Brand relationships

- **Inspired To Soar** (mention)
- **Cancer Research UK** (mention)

## Partnerships

Bami Adenipekun's posts do not set out a sponsorship, advertising or paid-partnership offer. Their work centres on convening: the Seen Heard Valued event on 9 September, bringing statutory and non-statutory sectors and community members into the same room, and a report focused on cancer care and racial disparities. A healthcare organisation should expect to join that agenda as a participant, contributor or co-convener rather than buy a defined sponsored-post or advertising package. Ask directly about deliverables, pricing, approval steps and usage terms; none are published here.

## Alternatives

- Pamela Shaddock: Choose Pamela Shaddock when a campaign narrows from convening a conversation to fixing a specific point of care inside the hospital — for example, what a Black patient is offered when cancer treatment causes hair loss. The posts describe co-founding Coils to Locs with sister Dianne Austin after Dianne could not find a wig that matched natural hair during breast cancer treatment in 2015, lost the value of the cranial prosthesis insurance benefit, and was sent to a supply room or a beauty store staff bathroom to try one on. The same posts report partnerships with 27+ hospitals and cancer centers, a stated goal of 40 hospital partners by the end of 2026, patient education work with the National Alopecia Areata Foundation, and grant and competition awards funding the next phase. If the deliverable is something a patient can actually receive in an oncology or hospital retail setting, this is the more concrete track record.
- Sina Haeri: Choose Sina Haeri when the need is clinical rather than community-facing, and the task is to design or commission high-risk obstetric care for Medicaid, rural or safety-net populations. The posts show an MFM physician arguing from published research — a JAMA Health Forum study of 172 venture-backed maternal health startups, including the finding that 52% of all capital went to three companies and only about 34% of startups whose services could accept Medicaid do — and a Commonwealth Fund brief on severe maternal morbidity. The same posts report that teleMFM implementation was associated with a 34% reduction in severe maternal morbidity at hospitals without prior MFM coverage, and describe Ouma Health as practising medicine rather than wellness for safety-net populations including Medicaid health plans, FQHCs and rural health systems. If the buyer needs an evidence-led clinical case for where care is missing, this is the stronger voice.
- Jean Stimola-Sposaro: Choose Jean Stimola-Sposaro when the need turns on patient data: who owns it, how consent is designed, and whether a digital-first service quietly excludes the people it was meant to reach. The posts annotate current literature — a two-round Delphi study in JMIR on decentralized clinical trial barriers in Europe, where 69% of otherwise eligible participants dropped out at the first digital consent screen, and a piece on IRT data ownership arguing that safety data collected for protocol-required monitoring belongs to the participant rather than to sponsor or investigator. The posts also flag where expert consensus broke down, on centralised ethics review and peer support. If the engagement involves collecting patient stories or health data, this is where the governance questions are laid out.

---
AI-assisted summary of public posts. Audience demographics are not available. Engagement appears only where we checked recent posts. Method: https://b2binfluencer.marketing/methodology/